Deficiency in Androgen Receptor Aggravates Traumatic Brain Injury-Induced Pathophysiology and Motor Deficits in Mice

Yu-Hsin Chen1, Yen-Chou Chen1, Ling-Ling Hwang1

  • 1Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.

Insights

Androgen receptors (ARs) are crucial for mitigating brain injury after TBI. AR knockout mice showed worsened outcomes, indicating ARs protect against TBI-related damage.

Area of Science:

  • Neuroscience
  • Traumatic Brain Injury Research
  • Molecular Biology

Background:

  • Androgens show neuroprotective effects post-brain injury, mediated by androgen receptors (ARs).
  • The specific role of ARs in traumatic brain injury (TBI) pathophysiology remains unclear.
  • Investigating ARs is vital for understanding TBI mechanisms and potential therapeutic targets.

Purpose of the Study:

  • To elucidate the role of androgen receptors (ARs) in the pathophysiology of traumatic brain injury (TBI).
  • To assess the impact of AR deficiency on neurological function and brain lesion development after TBI.
  • To evaluate the effects of AR knockout on cellular processes like necrosis and autophagy post-TBI.

Main Methods:

  • Utilized a controlled cortical impact model to induce TBI in AR knockout (ARKO) and wild-type mice.
  • Assessed motor function and quantified brain-lesion volume following TBI.
  • Evaluated markers of necrosis (alpha-II-spectrin breakdown product 150), astrogliosis (glial fibrillary acidic protein), and autophagy (Beclin-1) post-injury.

Main Results:

  • AR knockout significantly exacerbated TBI-induced expression of necrosis and astrogliosis markers.
  • Increased astrogliosis in ARKO mice persisted for three weeks post-TBI.
  • ARKO mice exhibited impaired motor function and larger brain lesions compared to wild-type controls.
  • Autophagy marker Beclin-1 was elevated in ARKO mice after TBI.

Conclusions:

  • Androgen receptors play a significant protective role in the context of traumatic brain injury.
  • AR deficiency leads to increased neuronal damage, inflammation, and functional deficits after TBI.
  • These findings highlight ARs as potential therapeutic targets for managing TBI.

Related Concept Videos